Evommune, Inc. (EVMN) Revenue (2025)
Evommune (EVMN) posted quarterly Revenue of $10.0 million for Q3 2025, up 233.33% sequentially from $3.0 million in Q1 2025.
Evommune, Inc. (EVMN) Revenue (2025) Analysis & Trends
Evommune has disclosed Revenue across 1 years of filings, most recently posting $10.0 million for Q3 2025.
- In Q3 2025, Revenue changed N/A year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $13.0 million (changed N/A YoY), while the FY2025 annual figure was $13.0 million, up 85.71% from the prior year.
- Revenue grew to $10.0 million in Q3 2025, from $3.0 million in the prior quarter.
- Over the last five years, Revenue for EVMN reached as high as $10.0 million in Q3 2025 and fell as low as $3.0 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 3.00 Mn |